Skip to main content

Advertisement

SpringerLink
Log in

Current concepts and strategies in the diagnosis and management of idiopathic intracranial hypertension in adults

  • Review
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Since obesity has become an epidemic in industrialized nations, idiopathic intracranial hypertension (IIH) is now a more common neuro-ophthalmic disorder that causes visual loss and headaches. This review highlights the new diagnostic criteria for IIH and the new insights into the pathophysiologic mechanisms of IIH. Key diagnostic and monitoring techniques for papilledema include not only neuroimaging and the measurement of cerebrospinal fluid (CSF) pressure, but also perimetry, optical coherence tomography, and ocular sonography. The main findings of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT) support acetazolamide as the mainstay for medical therapy. CSF diversion procedures, endovascular venous sinus stenting, and optic nerve sheath fenestration are all surgical options when IIH is refractory to medical treatment or when it presents fulminantly. Future clinical trials comparing these procedures will help develop better paradigms in the surgical management of IIH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Friesner D, Rosenman R, Lobb BM, Tanne E (2011) Idiopathic intracranial hypertension in the USA: the role of obesity in establishing prevalence and healthcare costs. Obes Rev 12(5):e372–e380

    Article  CAS  PubMed  Google Scholar 

  2. Phillips PH, Repka MX, Lambert SR (1998) Pseudotumor cerebri in children. J AAPOS 2(1):33–38

    Article  CAS  PubMed  Google Scholar 

  3. Lampl Y, Eshel Y, Kessler A, Fux A, Gilad R, Boaz M et al (2002) Serum leptin level in women with idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 72(5):642–643

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Wall M, Kupersmith MJ, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI et al (2014) The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol 71(6):693–701

    Article  PubMed  PubMed Central  Google Scholar 

  5. Yri HM, Jensen RH (2015) Idiopathic intracranial hypertension: clinical nosography and field-testing of the ICHD diagnostic criteria. A case–control study. Cephalalgia 35(7):553–562

    Article  PubMed  Google Scholar 

  6. Yri HM, Ronnback C, Wegener M, Hamann S, Jensen RH (2014) The course of headache in idiopathic intracranial hypertension: a 12-month prospective follow-up study. Eur J Neurol 21(12):1458–1464

    Article  CAS  PubMed  Google Scholar 

  7. Friedman DI, Liu GT, Digre KB (2013) Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 81(13):1159–1165

    Article  PubMed  Google Scholar 

  8. Wall M (2010) Idiopathic intracranial hypertension. Neurol Clin 28(3):593–617

    Article  PubMed  PubMed Central  Google Scholar 

  9. Libien J, Kupersmith MJ, Blaner W, McDermott MP, Gao S, Liu Y et al (2017) Role of vitamin A metabolism in IIH: results from the idiopathic intracranial hypertension treatment trial. J Neurol Sci 372:78–84

    Article  CAS  PubMed  Google Scholar 

  10. Vieira DS, Masruha MR, Goncalves AL, Zukerman E, Senne Soares CA, Naffah-Mazzacoratti Mda G et al (2008) Idiopathic intracranial hypertension with and without papilloedema in a consecutive series of patients with chronic migraine. Cephalalgia 28(6):609–613

    Article  CAS  PubMed  Google Scholar 

  11. De Simone R, Ranieri A, Bilo L, Fiorillo C, Bonavita V (2008) Cranial neuralgias: from physiopathology to pharmacological treatment. Neurol Sci 29(Suppl 1):S69–S78

    Article  PubMed  Google Scholar 

  12. De Simone R, Ranieri A (2015) The role of intracranial hypertension in the chronification of migraine. Neurol Sci 36(Suppl 1):23–28

    Article  PubMed  Google Scholar 

  13. Maralani PJ, Hassanlou M, Torres C, Chakraborty S, Kingstone M, Patel V et al (2012) Accuracy of brain imaging in the diagnosis of idiopathic intracranial hypertension. Clin Radiol 67(7):656–663

    Article  CAS  PubMed  Google Scholar 

  14. Kyung SE, Botelho JV, Horton JC (2014) Enlargement of the sella turcica in pseudotumor cerebri. J Neurosurg 120(2):538–542

    Article  PubMed  Google Scholar 

  15. Ranganathan S, Lee SH, Checkver A, Sklar E, Lam BL, Danton GH et al (2013) Magnetic resonance imaging finding of empty sella in obesity related idiopathic intracranial hypertension is associated with enlarged sella turcica. Neuroradiology 55(8):955–961

    Article  PubMed  PubMed Central  Google Scholar 

  16. Bidot S, Clough L, Saindane AM, Newman NJ, Biousse V, Bruce BB (2016) The Optic Canal Size Is Associated With the Severity of Papilledema and Poor Visual Function in Idiopathic Intracranial Hypertension. J Neuro-Ophthalmol: Off J N Am Neuro-Ophthalmol Soc 36(2):120–125

    Article  Google Scholar 

  17. Butros SR, Goncalves LF, Thompson D, Agarwal A, Lee HK (2012) Imaging features of idiopathic intracranial hypertension, including a new finding: widening of the foramen ovale. Acta Radiol 53(6):682–688

    Article  PubMed  Google Scholar 

  18. Saindane AM, Bruce BB (2014) Reply to “Enlarged CSF spaces in pseudotumor cerebri”. AJR Am J Roentgenol 203(4):W459

    Article  PubMed  Google Scholar 

  19. Bialer OY, Rueda MP, Bruce BB, Newman NJ, Biousse V, Saindane AM (2014) Meningoceles in idiopathic intracranial hypertension. AJR Am J Roentgenol 202(3):608–613

    Article  PubMed  PubMed Central  Google Scholar 

  20. Degnan AJ, Levy LM (2011) Narrowing of Meckel’s cave and cavernous sinus and enlargement of the optic nerve sheath in pseudotumor cerebri. J Comput Assist Tomogr 35(2):308–312

    Article  PubMed  Google Scholar 

  21. Farb RI, Vanek I, Scott JN, Mikulis DJ, Willinsky RA, Tomlinson G et al (2003) Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology 60(9):1418–1424

    Article  CAS  PubMed  Google Scholar 

  22. Rohr A, Bindeballe J, Riedel C, van Baalen A, Bartsch T, Doerner L et al (2012) The entire dural sinus tree is compressed in patients with idiopathic intracranial hypertension: a longitudinal, volumetric magnetic resonance imaging study. Neuroradiology 54(1):25–33

    Article  PubMed  Google Scholar 

  23. Horev A, Hallevy H, Plakht Y, Shorer Z, Wirguin I, Shelef I (2013) Changes in cerebral venous sinuses diameter after lumbar puncture in idiopathic intracranial hypertension: a prospective MRI study. J Neuroimaging 23(3):375–378

    Article  PubMed  Google Scholar 

  24. Bono F, Giliberto C, Mastrandrea C, Cristiano D, Lavano A, Fera F et al (2005) Transverse sinus stenoses persist after normalization of the CSF pressure in IIH. Neurology 65(7):1090–1093

    Article  CAS  PubMed  Google Scholar 

  25. Kimberly HH, Shah S, Marill K, Noble V (2008) Correlation of optic nerve sheath diameter with direct measurement of intracranial pressure. Acad Emerg Med 15(2):201–204

    Article  PubMed  Google Scholar 

  26. Bauerle J, Nedelmann M (2011) Sonographic assessment of the optic nerve sheath in idiopathic intracranial hypertension. J Neurol 258(11):2014–2019

    Article  PubMed  Google Scholar 

  27. Singleton J, Dagan A, Edlow JA, Hoffmann B (2015) Real-time optic nerve sheath diameter reduction measured with bedside ultrasound after therapeutic lumbar puncture in a patient with idiopathic intracranial hypertension. Am J Emerg Med 33(6):860 e5–860 e7

    Article  Google Scholar 

  28. Hassen GW, Nazeer O, Manizate F, Patel N, Kalantari H (2014) The role of bedside ultrasound in pretherapeutic and posttherapeutic lumbar puncture in patient with idiopathic intracranial hypertension. Am J Emerg Med 32(10):1298 e3–1298 e4

    Article  Google Scholar 

  29. Hoffmann J, Huppertz HJ, Schmidt C, Kunte H, Harms L, Klingebiel R et al (2013) Morphometric and volumetric MRI changes in idiopathic intracranial hypertension. Cephalalgia 33(13):1075–1084

    Article  PubMed  Google Scholar 

  30. Rauz S, Cheung CM, Wood PJ, Coca-Prados M, Walker EA, Murray PI et al (2003) Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 lowers intraocular pressure in patients with ocular hypertension. QJM 96(7):481–490

    Article  CAS  PubMed  Google Scholar 

  31. Sinclair AJ, Walker EA, Burdon MA, van Beek AP, Kema IP, Hughes BA et al (2010) Cerebrospinal fluid corticosteroid levels and cortisol metabolism in patients with idiopathic intracranial hypertension: a link between 11beta-HSD1 and intracranial pressure regulation? J Clin Endocrinol Metab 95(12):5348–5356

    Article  CAS  PubMed  Google Scholar 

  32. Boyle CD (2008) Recent advances in the discovery of 11beta-HSD1 inhibitors. Curr Opin Drug Discov Dev 11(4):495–511

    CAS  Google Scholar 

  33. Markey KA, Uldall M, Botfield H, Cato LD, Miah MA, Hassan-Smith G et al (2016) Idiopathic intracranial hypertension, hormones, and 11beta-hydroxysteroid dehydrogenases. J Pain Res 9:223–232

    PubMed  PubMed Central  Google Scholar 

  34. Mollan SP, Ali F, Hassan-Smith G, Botfield H, Friedman DI, Sinclair AJ (2016) Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management. J Neurol Neurosurg Psychiatry 87(9):982–992

    Article  PubMed  PubMed Central  Google Scholar 

  35. Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA et al (2012) A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med 4(147):147ra11

    Article  Google Scholar 

  36. Orefice G, Celentano L, Scaglione M, Davoli M, Striano S (1992) Radioisotopic cisternography in benign intracranial hypertension of young obese women. A seven-case study and pathogenetic suggestions. Acta Neurol (Napoli) 14(1):39–50

    CAS  Google Scholar 

  37. Levitt MR, Albuquerque FC, Gross BA, Moon K, Jadhav AP, Ducruet AF et al (2016) Venous sinus stenting in patients without idiopathic intracranial hypertension. J Neurointerv Surg. doi:10.1136/neurintsurg-2016-012405

    Google Scholar 

  38. Subramaniam S, Fletcher WA (2016) Obesity and weight loss in idiopathic intracranial hypertension: a narrative review. J Neuroophthalmol. doi:10.1097/WNO.0000000000000448

    Google Scholar 

  39. Berdahl JP, Fleischman D, Zaydlarova J, Stinnett S, Allingham RR, Fautsch MP (2012) Body mass index has a linear relationship with cerebrospinal fluid pressure. Investig Ophthalmol Vis Sci 53(3):1422–1427

    Article  Google Scholar 

  40. Kesler A, Kliper E, Shenkerman G, Stern N (2010) Idiopathic intracranial hypertension is associated with lower body adiposity. Ophthalmology 117(1):169–174

    Article  PubMed  Google Scholar 

  41. Ball AK, Sinclair AJ, Curnow SJ, Tomlinson JW, Burdon MA, Walker EA et al (2009) Elevated cerebrospinal fluid (CSF) leptin in idiopathic intracranial hypertension (IIH): evidence for hypothalamic leptin resistance? Clin Endocrinol (Oxf) 70(6):863–869

    Article  CAS  Google Scholar 

  42. Klein A, Stern N, Osher E, Kliper E, Kesler A (2013) Hyperandrogenism is associated with earlier age of onset of idiopathic intracranial hypertension in women. Curr Eye Res 38(9):972–976

    Article  CAS  PubMed  Google Scholar 

  43. Kerty E, Heuser K, Indahl UG, Berg PR, Nakken S, Lien S et al (2013) Is the brain water channel aquaporin-4 a pathogenetic factor in idiopathic intracranial hypertension? Results from a combined clinical and genetic study in a Norwegian cohort. Acta Ophthalmol 91(1):88–91

    Article  CAS  PubMed  Google Scholar 

  44. Stiebel-Kalish H, Eyal S, Steiner I (2013) The role of aquaporin-1 in idiopathic and drug-induced intracranial hypertension. Med Hypotheses 81(6):1059–1062

    Article  CAS  PubMed  Google Scholar 

  45. Brettschneider J, Hartmann N, Lehmensiek V, Mogel H, Ludolph AC, Tumani H (2011) Cerebrospinal fluid markers of idiopathic intracranial hypertension: is the renin-angiotensinogen system involved? Cephalalgia 31(1):116–121

    Article  PubMed  Google Scholar 

  46. Edwards LJ, Sharrack B, Ismail A, Tench CR, Gran B, Dhungana S et al (2013) Increased levels of interleukins 2 and 17 in the cerebrospinal fluid of patients with idiopathic intracranial hypertension. Am J Clin Exp Immunol 2(3):234–244

    PubMed  PubMed Central  Google Scholar 

  47. Keltner JL, Johnson CA, Cello KE, Wall M (2014) Group NIIHS. Baseline visual field findings in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT). Investig Ophthalmol Vis Sci 55(5):3200–3207

    Article  Google Scholar 

  48. Wall M, Johnson CA, Cello KE, Zamba KD, McDermott MP, Keltner JL et al (2016) Visual field outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT). Investig Ophthalmol Vis Sci 57(3):805–812

    Article  CAS  Google Scholar 

  49. Corbett JJ, Jacobson DM, Mauer RC, Thompson HS (1988) Enlargement of the blind spot caused by papilledema. Am J Ophthalmol 105(3):261–265

    Article  CAS  PubMed  Google Scholar 

  50. Cello KE, Keltner JL, Johnson CA, Wall M, Group NIIHS (2016) Factors affecting visual field outcomes in the Idiopathic Intracranial Hypertension Treatment Trial. J Neuro-Ophthalmol: Off J N Am Neuro-Ophthalmol Soc 36(1):6–12

    Article  Google Scholar 

  51. Kardon R (2014) Optical coherence tomography in papilledema: what am I missing? J Neuro-Ophthalmol: Off J N Am Neuro-Ophthalmol Soc 34(Suppl):S10–S17

    Article  Google Scholar 

  52. Group OCTS-SCfNIIHS, Auinger P, Durbin M, Feldon S, Garvin M, Kardon R et al (2014) Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features. Investig Ophthalmol Vis Sci 55(12):8173–8179

  53. Kupersmith MJ, Sibony P, Mandel G, Durbin M, Kardon RH (2011) Optical coherence tomography of the swollen optic nerve head: deformation of the peripapillary retinal pigment epithelium layer in papilledema. Investig Ophthalmol Vis Sci 52(9):6558–6564

    Article  Google Scholar 

  54. Sibony P, Kupersmith MJ, Honkanen R, Rohlf FJ, Torab-Parhiz A (2014) Effects of lowering cerebrospinal fluid pressure on the shape of the peripapillary retina in intracranial hypertension. Investig Ophthalmol Vis Sci 55(12):8223–8231

    Article  Google Scholar 

  55. Silverman AL, Tatham AJ, Medeiros FA, Weinreb RN (2014) Assessment of optic nerve head drusen using enhanced depth imaging and swept source optical coherence tomography. J Neuro-Ophthalmol: Off J N Am Neuro-Ophthalmol Soc 34(2):198–205

    Article  Google Scholar 

  56. Optical Coherence Tomography Substudy Committee, NORDIC Idiopathic Intracranial Hypertension Study Group (2015) Papilledema Outcomes from the Optical Coherence Tomography Substudy of the Idiopathic Intracranial Hypertension Treatment Trial. Ophthalmology 122(9):1939–1945

    Article  Google Scholar 

  57. Chowdhury HR, Rajak S, Heath D, Brittain P (2015) Optical coherence tomography imaging of the optic nerve head pre optic and post optic nerve sheath fenestration. BMJ Case Rep. doi:10.1136/bcr-2014-204511

    Google Scholar 

  58. Monteiro ML, Afonso CL (2014) Macular thickness measurements with frequency domain-OCT for quantification of axonal loss in chronic papilledema from pseudotumor cerebri syndrome. Eye (London) 28(4):390–398

    Article  CAS  Google Scholar 

  59. Afonso CL, Raza AS, Kreuz AC, Hokazono K, Cunha LP, Oyamada MK et al (2015) Relationship between pattern electroretinogram, frequency-domain OCT, and automated perimetry in chronic papilledema from pseudotumor cerebri syndrome. Invest Ophthalmol Vis Sci 56(6):3656–3665

    Article  CAS  PubMed  Google Scholar 

  60. Goldhagen BE, Bhatti MT, Srinivasan PP, Chiu SJ, Farsiu S, El-Dairi MA (2015) Retinal atrophy in eyes with resolved papilledema detected by optical coherence tomography. J Neuro-Ophthalmol: Off J N Am Neuro-Ophthalmol Soc 35(2):122–126

    Google Scholar 

  61. Ohle R, McIsaac SM, Woo MY, Perry JJ (2015) Sonography of the optic nerve sheath diameter for detection of raised intracranial pressure compared to computed tomography: a systematic review and meta-analysis. J Ultrasound Med 34(7):1285–1294

    Article  PubMed  Google Scholar 

  62. Bagnato F, Good J (2016) The use of antiepileptics in migraine prophylaxis. Headache 56(3):603–615

    Article  PubMed  Google Scholar 

  63. Friedman DI, McDermott MP, Kieburtz K, Kupersmith M, Stoutenburg A, Keltner JL et al (2014) The idiopathic intracranial hypertension treatment trial: design considerations and methods. J Neuro-Ophthalmol: Off J N Am Neuro-Ophthalmol Soc 34(2):107–117

    Article  Google Scholar 

  64. Kupersmith MJ, Gamell L, Turbin R, Peck V, Spiegel P, Wall M (1998) Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology 50(4):1094–1098

    Article  CAS  PubMed  Google Scholar 

  65. Levy J, Yagev R, Petrova A, Lifshitz T (2006) Topiramate-induced bilateral angle-closure glaucoma. Can J Ophthalmol 41(2):221–225

    Article  PubMed  Google Scholar 

  66. Giuliari GP, Banda RM, Vann VR, Gonzalez VH, McMillin RB (2008) Closed-angle glaucoma after topiramate therapy for migraine in a patient with undiagnosed pseudotumor cerebri. Can J Ophthalmol 43(3):371

    Article  PubMed  Google Scholar 

  67. Alore PL, Jay WM, Macken MP (2006) Topiramate, pseudotumor cerebri, weight-loss and glaucoma: an ophthalmologic perspective. Semin Ophthalmol 21(1):15–17

    Article  PubMed  Google Scholar 

  68. Celebisoy N, Gokcay F, Sirin H, Akyurekli O (2007) Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand 116(5):322–327

    Article  CAS  PubMed  Google Scholar 

  69. Mathew NT, Ravishankar K, Sanin LC (1996) Coexistence of migraine and idiopathic intracranial hypertension without papilledema. Neurology 46(5):1226–1230

    Article  CAS  PubMed  Google Scholar 

  70. Yri HM, Wegener M, Sander B, Jensen R (2012) Idiopathic intracranial hypertension is not benign: a long-term outcome study. J Neurol 259(5):886–894

    Article  PubMed  Google Scholar 

  71. Satti SR, Leishangthem L, Chaudry MI (2015) Meta-analysis of CSF diversion procedures and dural venous sinus stenting in the setting of medically refractory idiopathic intracranial hypertension. AJNR Am J Neuroradiol 36(10):1899–1904

    Article  CAS  PubMed  Google Scholar 

  72. Brodsky MC, Rettele GA (1998) Protracted postsurgical blindness with visual recovery following optic nerve sheath fenestration. Arch Ophthalmol 116(1):107–109

    CAS  PubMed  Google Scholar 

  73. Robinson ME, Moreau A, O’Meilia R, Pagteilan J, Ding K, Siatkowski RM et al (2016) The relationship between optic nerve sheath decompression failure and intracranial pressure in idiopathic intracranial hypertension. J Neuro-Ophthalmol: Off J N Am Neuro-Ophthalmol Soc 36(3):246–251

    Article  Google Scholar 

  74. Woodworth GF, McGirt MJ, Elfert P, Sciubba DM, Rigamonti D (2005) Frameless stereotactic ventricular shunt placement for idiopathic intracranial hypertension. Stereotact Funct Neurosurg 83(1):12–16

    Article  PubMed  Google Scholar 

  75. Kandasamy J, Hayhurst C, Clark S, Jenkinson MD, Byrne P, Karabatsou K et al (2011) Electromagnetic stereotactic ventriculoperitoneal csf shunting for idiopathic intracranial hypertension: a successful step forward? World Neurosurg. 75(1):155–160 (discussion 32–3)

    Article  PubMed  Google Scholar 

  76. Alkosha HM, Zidan AS (2016) Role of lumbopleural shunt in management of idiopathic intracranial hypertension. World Neurosurg 88:113–118

    Article  PubMed  Google Scholar 

  77. Radvany MG, Solomon D, Nijjar S, Subramanian PS, Miller NR, Rigamonti D et al (2013) Visual and neurological outcomes following endovascular stenting for pseudotumor cerebri associated with transverse sinus stenosis. J Neuro-Ophthalmol: Off J N Am Neuro-Ophthalmol Soc 33(2):117–122

    Article  Google Scholar 

  78. Dinkin MJ, Patsalides A (2016) Venous sinus stenting in idiopathic intracranial hypertension: results of a prospective trial. J Neuroophthalmol. doi:10.1097/WNO.0000000000000426

    PubMed  Google Scholar 

  79. Ahmed RM, Wilkinson M, Parker GD, Thurtell MJ, Macdonald J, McCluskey PJ et al (2011) Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 patients and of model predictions. AJNR Am J Neuroradiol 32(8):1408–1414

    Article  CAS  PubMed  Google Scholar 

  80. Ahmed R, Friedman DI, Halmagyi GM (2011) Stenting of the transverse sinuses in idiopathic intracranial hypertension. J Neuro-Ophthalmol: Off J N Am Neuro-Ophthalmol Soc 31(4):374–380

    Article  Google Scholar 

  81. American College of Cardiology/American Heart Association Task Force on Practice Guidelines OEP (2013) Executive summary: Guidelines for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society published by the Obesity Society and American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Based on a systematic review from the The Obesity Expert Panel, 2013. Obesity (Silver Spring) 22(Suppl 2):S5–S39

  82. Handley SC, Sun Y, Wyckoff MH, Lee HC (2015) Outcomes of extremely preterm infants after delivery room cardiopulmonary resuscitation in a population-based cohort. J Perinatol 35(5):379–383

    Article  CAS  PubMed  Google Scholar 

  83. Moss HE (2016) Bariatric Surgery and the Neuro-Ophthalmologist. J Neuro-Ophthalmol: Off J N Am Neuro-Ophthalmol Soc 36(1):78–84

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Neurology and Ophthalmology, University of Arizona College of Medicine, Phoenix, AZ, USA

    Jane W. Chan

Authors
  1. Jane W. Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jane W. Chan.

Ethics declarations

Conflicts of interest

No competing or conflicts of interest and no funding sources declared.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chan, J.W. Current concepts and strategies in the diagnosis and management of idiopathic intracranial hypertension in adults. J Neurol 264, 1622–1633 (2017). https://doi.org/10.1007/s00415-017-8401-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-017-8401-7

Keywords

Search

Navigation